Senju Pharmaceutical: Agarose Sodium Glucose Injection Receives Drug Registration Certificate

Xianju Pharmaceutical announced that the company's collaboration product with Hangzhou Aomer, Argatroban Sodium Injection, has recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration. The registration category is Class 1 chemical drugs, with a dosage form specification of 2ml: 250mg. This drug is a specific muscle relaxant antagonist, mainly used to antagonize the neuromuscular blockade induced by rocuronium bromide. Hangzhou Aomer is the holder of the marketing authorization, Xianju Pharmaceutical is the manufacturing enterprise, and Xianju Pharmaceutical holds the approval documents for the raw materials. Previously, Xianju Pharmaceutical and Hangzhou Aomer had jointly authorized Aishijian Company as the exclusive marketing service provider for this product in China.